MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1007/s12664-013-0374-6

Медицинская библиотека · Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology · 2013

Prevalence of TPMT polymorphism in Indian patients requiring immunomodulator therapy and its clinical significance.

Davavala Sandeep Kirit, Desai Devendra C, Abraham Philip, Ashavaid Tester, Joshi Anand, Gupta Tarun

СтатьяПеревод пока не подготовлен

Аннотация

BACKGROUND

Thiopurine methyltransferase (TPMT) enzyme plays a key role in the metabolism of azathioprine/6-mercaptopurine (6-MP). Mutations in the enzyme lead to generation of excess thioguanine, which causes suppression of various cell lineages, especially neutrophils. Data on the prevalence of TPMT polymorphism are available from Western and some Asian countries; such data from India are sparse.

AIMS: The aim of this research is to study the prevalence of TPMT mutation in Indian patients requiring immunomodulator therapy and its relation to the development of neutropenia on azathioprine therapy.

METHODS

In this retrospective study, data of all patients who underwent TPMT genotyping by PCR-RFLP and allele-specific PCR prior to immunomodulator therapy were analyzed. The frequency of on-treatment development of neutropenia (total neutrophil count <1,500 per cubic millimeters) was noted.

RESULTS

Data were available on 126 patients (mean age, 42 [SD 13.6] years; 73 men and 53 women). The disease indications included ulcerative colitis (61), Crohn's disease (43), indeterminate colitis (1), autoimmune hepatitis (16), and others (5). TPMT genotype was wild in 120 patients (95.23 %) and heterozygous in 6 patients (4.77 %); no patient had homozygous mutation. Seven of 87 patients (6.8 %) who received azathioprine developed neutropenia; blood counts normalized on cessation of the drug in all. The incidence of neutropenia in patients with wild type was 6/84 (7.14 %) and with heterozygous type 1/3 (33 %) (p = 0.5764).

CONCLUSION

Nearly 5 % of this population of patients requiring immunomodulator therapy was heterozygous carriers of the TPMT gene. Neutropenia was equally common in patients without and with the mutation.

Для цитирования: Davavala Sandeep Kirit, Desai Devendra C, Abraham Philip, Ashavaid Tester, Joshi Anand, Gupta Tarun. Prevalence of TPMT polymorphism in Indian patients requiring immunomodulator therapy and its clinical significance.. Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology. 2013. DOI: 10.1007/s12664-013-0374-6.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.